Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies

Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc). However, mortality is improving as pathogenesis is being better understood and new therapies emerge. The roles of the inflammasome and NETosis in fibrosis are being elucidated. Epigenetic targets like DNA me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Sakir, Pattanaik, Sarit Sekhar, Rai, Mohit Kumar, Nath, Alok, Agarwal, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046043/
https://www.ncbi.nlm.nih.gov/pubmed/32185315
http://dx.doi.org/10.31138/mjr.29.3.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046043/
https://www.ncbi.nlm.nih.gov/pubmed/32185315
http://dx.doi.org/10.31138/mjr.29.3.140

Ejemplares similares